Biosyent Investor Relations Material
Latest events
Q4 2024
Biosyent
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biosyent Inc
Access all reports
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada. It focuses on the acquisition of oncology drugs, medical devices and other healthcare products. BioSyent Inc. is based in Mississauga, Canada.
Key slides for Biosyent Inc
Q4 2024
Biosyent Inc
Q4 2024
Biosyent Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RX
Country
🇨🇦 Canada